Nuclear Imaging Equipment Market Size, Trends & Forecast 2034

Nuclear Imaging Equipment Market Outlook

The sales of nuclear imaging equipment are estimated to evolve at a CAGR of 5.4% between 2024 and 2034. The nuclear imaging equipment market size is expected to expand from US$ 3 billion in 2024 to US$ 5.1 billion through 2034.

Due to applied research and technological improvements, the nuclear imaging device market has been expanding steadily. The aging population's heart and neurological conditions, as well as the rising rate of cancer, are contributing factors to the nuclear imaging equipment market’s upward trend.

The nuclear imaging equipment industry is growing faster due to better healthcare facilities, more diagnostic imaging centers, better health insurance, and more advantageous reimbursement practices in emerging economies.

Attributes	Details
Market Value for 2024	US$ 3 billion
Market Value for 2034	US$ 5.1 billion
Market CAGR from 2024 to 2034	5.4%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Prime Movers of Growth in the Nuclear Imaging Equipment Market

A key factor propelling the nuclear imaging device market is the rising incidence of chronic illnesses like cancer, heart problems, and neurological disorders. Modern diagnostic technologies are frequently needed for an accurate and timely diagnosis of certain medical disorders.
The increase in the growth of the nuclear imaging instrument market is mostly due to government initiatives, investments, and funds that support the development of healthcare infrastructure, research, and new diagnostic technologies.
Combined with other imaging modalities, nuclear imaging offers full diagnostic data. The adoption of nuclear imaging equipment in conjunction with other imaging technologies is encouraged by this trend.
Age-related illnesses and ailments are becoming common as the world's population ages. Nuclear imaging is essential for identifying and tracking these health problems in the senior population, which elevates demand for nuclear imaging equipment.

Attributes	Details
Market Value for 2019	US$ 2.1 billion
Market Value for 2023	US$ 2.8 billion
Market CAGR from 2019 to 2023	7.1%

Impediments to Market Advancement in Nuclear Imaging Equipment

Nuclear imaging equipment has a significant initial cost. This expense for healthcare facilities, especially those with tight resources, is hampered by the widespread adoption of nuclear imaging equipment.
There are ambiguous or restricted payment guidelines for nuclear imaging treatments. This affects the nuclear imaging equipment demand by posing financial difficulties for patients and healthcare providers.
Nuclear imaging equipment operation and result interpretation call for specific training. Nuclear imaging technologies are not widely adopted because of the scarcity of specialists with the necessary training due to the intricacy of these processes.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Outlook

In the segmented nuclear imaging equipment market analysis, SPECT systems emerge as the prevalent product category endowed by expansive research. Within applications, oncology leads the way, supported by comprehensive studies.

These discoveries underscore the significance of SPECT systems in diagnosing various conditions, particularly in oncology, reflecting a trend toward precision medicine and targeted therapies.

SPECT Systems Align with Evolving Healthcare Demands

Attributes	Details
Top Product	SPECT Systems
CAGR % 2019 to 2023	6.9%
CAGR % 2024 to End of Forecast (2034)	5.1%

Due to their practicality and affordability, SPECT systems are a prevalent option in the nuclear imaging equipment market.
The market leadership of SPECT is a result of its proven track record in diagnostic imaging, which gives prospective customers trust.
SPECT systems are progressively common because of their efficiency and practicality, which meet the changing needs of healthcare practitioners.
SPECT systems are widely used in business, and this highlights their importance and potential for high returns on investment when companies formulate their strategies.

Oncology's Dominance in Sales of Nuclear Imaging Equipment

Attributes	Details
Top Application	Oncology
CAGR % 2019 to 2023	6.6%
CAGR % 2024 to End of Forecast (2034)	4.8%

The growing need for precise cancer diagnosis and staging propels the adoption of nuclear imaging equipment.
Nuclear imaging strengthens its market domination and is critical in oncology therapy planning and response assessment.
The healthcare industry purchases nuclear imaging equipment due to ongoing developments in oncology imaging procedures.
Nuclear imaging equipment is in high demand in oncology due to growing knowledge of the advantages of early cancer detection.

Country-wise Analysis

Tables highlighting South Korea, Japan, China, the United States, and the United Kingdom illustrate the market's considerable potential for nuclear imaging equipment. Based on a comprehensive analysis, South Korea is considered especially promising, offering significant growth potential in the global nuclear imaging equipment market.

Rising Healthcare Expenditure Spurs Demand for Nuclear Imaging Equipment in South Korea

Country	South Korea
HCAGR (2019 to 2023)	11.4%
CAGR (2024 to 2034)	7.2%

The demand for nuclear imaging equipment is influenced by the increased incidence of chronic diseases and rising healthcare costs in South Korea.
South Korea nuclear imaging device market to reach a valuation of US$ 304 million by 2034.
Robust research and development programs in nuclear medicine facilitate the evolution of imaging technology in South Korea.
South Korea has a rising demand for nuclear imaging equipment due to the emphasis on early disease identification and preventative healthcare.

Aging Population Stimulates Demand for Advanced Nuclear Imaging Solutions in Japan

Country	Japan
HCAGR (2019 to 2023)	9.4%
CAGR (2024 to 2034)	6.5%

The demand for nuclear imaging technology for diagnosis and treatment planning is fostered by Japan's aging population and high cancer incidence.
The introduction of modern nuclear imaging technologies in Japan is spurred by government programs promoting customized healthcare and precision medicine.
Japan nuclear imaging system market to achieve a worth of US$ 597.6 million by 2034.
Japan's nuclear imaging equipment market is expanding due to rising healthcare spending and growing public awareness of the advantages of early disease detection.

Rapid Urbanization Boosts Nuclear Imaging Equipment Market in China

Country	China
HCAGR (2019 to 2023)	8.8%
CAGR (2024 to 2034)	6.3%

The country's booming medical tourism industry and developing healthcare infrastructure are the primary catalysts of China's demand for nuclear imaging equipment.
China nuclear imaging technology market to attain a valuation of US$ 799.4 million by 2034.
The adoption of nuclear imaging technology for precise diagnosis and treatment monitoring is growing in China due to the country's rising rates of cancer and cardiovascular illnesses.
China's nuclear imaging tool market is growing partly due to the country's rapid urbanization and rising disposable incomes.

Technological Innovations Accelerate Nuclear Imaging Equipment Market Expansion in the United States

Country	United States
HCAGR (2019 to 2023)	7.8%
CAGR (2024 to 2034)	5.7%

Investments in nuclear imaging equipment are encouraged in the United States by favorable reimbursement rules and a supportive regulatory environment.
The United States is adopting nuclear imaging technology at a faster rate due to the growing frequency of chronic diseases and the increased desire for minimally invasive procedures.
The United States nuclear imaging instrument market to acquire worth US$ 903.4 million by 2034.
Nuclear imaging equipment is in high demand in the United States owing to technological advancements, including hybrid imaging systems.

Growing Focus on Early Disease Detection Strengthens Nuclear Imaging Equipment Demand in the United Kingdom

Country	United Kingdom
HCAGR (2019 to 2023)	5.3%
CAGR (2024 to 2034)	4.3%

A growing emphasis on customized medicine and early disease diagnosis prompts the United Kingdom's demand for nuclear imaging equipment.
The United Kingdom nuclear imaging tool market to attain a valuation of US$ 162 million by 2034.
Research and development investments facilitate the development and innovation of nuclear imaging technology in the United Kingdom.
The demand for nuclear imaging equipment in the United Kingdom's healthcare sector is bolstered by a growing understanding of the advantages of nuclear medicine.

Competitive Analysis

A few nuclear imaging equipment manufacturers control a large portion of the market, which fosters innovation and shapes the sector. Leading the way are reputable companies with a track record of innovation, such as Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V. The nuclear imaging equipment vendors push the envelope and establish standards for nuclear imaging technology improvements.

Other prominent nuclear imaging equipment providers, like Toshiba Corporation and Hitachi Ltd., enhance the competitive landscape with various products and services by bringing their knowledge and contributions. These producers use their advantages in manufacturing, research and development, and research to stay ahead of the nuclear imaging equipment market.

Emerging nuclear imaging equipment producers, such as Canon Medical Systems Corporation and Neusoft Medical Systems Co., Ltd., challenge conventional wisdom and spur competitiveness by bringing new ideas and inventiveness. The nuclear imaging tool market is partly dynamic because of its adaptability and commitment to meeting changing client needs.

The market's competitive dynamics are shaped by regional nuclear imaging equipment suppliers and niche specialists that provide specialized services to target market segments and geographic areas. The demand is defined by fierce competition among major nuclear imaging equipment manufacturers fueled by innovation, dependability, and a never-ending quest for excellence, guaranteeing ongoing breakthroughs and better patient outcomes.

Notable Developments

Company	Details
Koninklijke Philips N.V.	Mercurius Health, Elekta, and Koninklijke Philips N.V. announced in May 2023 a three-year contract under which Mercurius Health is going to set up informatics solutions and diagnostic and therapeutic oncology equipment from Elekta at the recently acquired Robert Janker Klinik cancer center in Bonn, Germany.
Bartec Technologies Ltd.	The United Kingdom-based business Bartec Technologies Ltd., which specializes in providing, installing, and maintaining accessories and equipment for nuclear medicine and molecular imaging, was acquired by Mediso Ltd. in April 2022. It is anticipated that this acquisition will enhance Mediso's standing in the marketplaces in the UK and Ireland.
Siemens Healthineers	Siemens Healthineers unveiled the Symbia Pro. specta, a SPECT/CT system that the FDA and CE have approved marked, in June 2022. Advanced SPECT and CT imaging technologies are included in this system. Among the noteworthy characteristics is a low-dose CT that can record up to 64 slices and provide detailed imaging.
Canon, Inc.	Canon, Inc. decided to create a brand-new company in November 2022, naming it Canon Healthcare the United States of America INC. By strengthening its position in the United States medical market, Canon contributed to the growth of the medical industry.

Vital Nuclear Imaging Equipment Manufacturers

Philips Healthcare
GE Healthcare
Siemens Healthineers AG
Digirad Corporation
Mediso Medical Imaging Systems Ltd
DDD-Diagnostics A/S
Neusoft Medical Systems Co. Ltd.
SurgicEye GmbH
CMR Naviscan Corporation

Key Coverage in Nuclear Imaging Equipment Market Report

Competitive Dynamics Insights for Nuclear Imaging Equipment Market
Demand for Nuclear Imaging Equipment in South Korea
Market Opportunities for Nuclear Imaging Equipment in Japan
Adjacent Study on the Nuclear Imaging Tool Market, Nuclear Medicine Equipment Market, and Molecular Imaging Market
Competition Analysis of Nuclear Imaging System Market with a Focus on Koninklijke Philips N.V., Bartec Technologies Ltd., and Siemens Healthineers

Key Segments

By Product:

SPECT Systems
Hybrid PET Systems
Planar Scintigraphy

By Application:

Oncology
Cardiology
Neurology
Others

By End-user:

Hospitals
Imaging Centers
Academic and Research Centers
Others

By Region:

North America
Europe
Asia Pacific
Middle East Asia
Latin America

Frequently Asked Questions

What is the Current Nuclear Imaging Equipment Market Valuation?

The nuclear imaging device market to secure a valuation of US$ 3 billion in 2024.

How Big Can the Nuclear Imaging Equipment Market Be by 2034?

The nuclear imaging instrument market is estimated to reach US$ 5.1 billion by 2034.

What is the Growth Potential of the Nuclear Imaging Equipment Market?

Through 2034, the nuclear imaging system market is anticipated to expand at a 5.4% CAGR.

What Was the Historical Outlook of The Nuclear Imaging Equipment Market?

From 2019 to 2023, the nuclear imaging tool market recorded a 7.1% HCAGR.

Which Product Segment to Dominate in the Nuclear Imaging Equipment Market?

The SPECT systems sector is set to accelerate at a CAGR of 5.1% from 2024 to 2034.

Which Application Segment to Lead the Nuclear Imaging Equipment Market?

The oncology sector is predicted to thrive at a CAGR of 4.8% through 2034.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Supply Chain Analysis

3.5.1. Supply Side Participants and their Roles

3.5.1.1. Producers

3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

3.5.1.3. Wholesalers and Distributors

3.5.2. Value Added and Value Created at Node in the Supply Chain

3.5.3. List of Raw Material Suppliers

3.5.4. List of Existing and Potential Buyer’s

3.6. Investment Feasibility Matrix

3.7. Value Chain Analysis

3.7.1. Profit Margin Analysis

3.7.2. Wholesalers and Distributors

3.7.3. Retailers

3.8. PESTLE and Porter’s Analysis

3.9. Regulatory Landscape

3.9.1. By Key Regions

3.9.2. By Key Countries

3.10. Regional Parent Market Outlook

3.11. Production and Consumption Statistics

3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023

4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023

5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034

5.3.1. SPECT Systems

5.3.2. Hybrid PET Systems

5.3.3. Planar Scintigraphy

5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023

5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2019 to 2023

6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2024 to 2034

6.3.1. Oncology

6.3.2. Cardiology

6.3.3. Neurology

6.3.4. Others

6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2019 to 2023

7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2024 to 2034

7.3.1. Hospitals

7.3.2. Imaging Centers

7.3.3. Academic and Research Centers

7.3.4. Others

7.4. Y-o-Y Growth Trend Analysis By End-User, 2019 to 2023

7.5. Absolute $ Opportunity Analysis By End-User, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023

8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. South Asia and Pacific

8.3.6. East Asia

8.3.7. Middle East and Africa

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

9.2.1. By Country

9.2.1.1. USA

9.2.1.2. Canada

9.2.2. By Product

9.2.3. By Application

9.2.4. By End-User

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product

9.3.3. By Application

9.3.4. By End-User

9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Product

10.2.3. By Application

10.2.4. By End-User

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product

10.3.3. By Application

10.3.4. By End-User

10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. UK

11.2.1.3. France

11.2.1.4. Spain

11.2.1.5. Italy

11.2.1.6. Rest of Western Europe

11.2.2. By Product

11.2.3. By Application

11.2.4. By End-User

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product

11.3.3. By Application

11.3.4. By End-User

11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

12.2.1. By Country

12.2.1.1. Poland

12.2.1.2. Russia

12.2.1.3. Czech Republic

12.2.1.4. Romania

12.2.1.5. Rest of Eastern Europe

12.2.2. By Product

12.2.3. By Application

12.2.4. By End-User

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product

12.3.3. By Application

12.3.4. By End-User

12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

13.2.1. By Country

13.2.1.1. India

13.2.1.2. Bangladesh

13.2.1.3. Australia

13.2.1.4. New Zealand

13.2.1.5. Rest of South Asia and Pacific

13.2.2. By Product

13.2.3. By Application

13.2.4. By End-User

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product

13.3.3. By Application

13.3.4. By End-User

13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

14.2.1. By Country

14.2.1.1. China

14.2.1.2. Japan

14.2.1.3. South Korea

14.2.2. By Product

14.2.3. By Application

14.2.4. By End-User

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Product

14.3.3. By Application

14.3.4. By End-User

14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

15.2.1. By Country

15.2.1.1. GCC Countries

15.2.1.2. South Africa

15.2.1.3. Israel

15.2.1.4. Rest of MEA

15.2.2. By Product

15.2.3. By Application

15.2.4. By End-User

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Product

15.3.3. By Application

15.3.4. By End-User

15.4. Key Takeaways

16. Key Countries Market Analysis

16.1. USA

16.1.1. Pricing Analysis

16.1.2. Market Share Analysis, 2023

16.1.2.1. By Product

16.1.2.2. By Application

16.1.2.3. By End-User

16.2. Canada

16.2.1. Pricing Analysis

16.2.2. Market Share Analysis, 2023

16.2.2.1. By Product

16.2.2.2. By Application

16.2.2.3. By End-User

16.3. Brazil

16.3.1. Pricing Analysis

16.3.2. Market Share Analysis, 2023

16.3.2.1. By Product

16.3.2.2. By Application

16.3.2.3. By End-User

16.4. Mexico

16.4.1. Pricing Analysis

16.4.2. Market Share Analysis, 2023

16.4.2.1. By Product

16.4.2.2. By Application

16.4.2.3. By End-User

16.5. Germany

16.5.1. Pricing Analysis

16.5.2. Market Share Analysis, 2023

16.5.2.1. By Product

16.5.2.2. By Application

16.5.2.3. By End-User

16.6. UK

16.6.1. Pricing Analysis

16.6.2. Market Share Analysis, 2023

16.6.2.1. By Product

16.6.2.2. By Application

16.6.2.3. By End-User

16.7. France

16.7.1. Pricing Analysis

16.7.2. Market Share Analysis, 2023

16.7.2.1. By Product

16.7.2.2. By Application

16.7.2.3. By End-User

16.8. Spain

16.8.1. Pricing Analysis

16.8.2. Market Share Analysis, 2023

16.8.2.1. By Product

16.8.2.2. By Application

16.8.2.3. By End-User

16.9. Italy

16.9.1. Pricing Analysis

16.9.2. Market Share Analysis, 2023

16.9.2.1. By Product

16.9.2.2. By Application

16.9.2.3. By End-User

16.10. Poland

16.10.1. Pricing Analysis

16.10.2. Market Share Analysis, 2023

16.10.2.1. By Product

16.10.2.2. By Application

16.10.2.3. By End-User

16.11. Russia

16.11.1. Pricing Analysis

16.11.2. Market Share Analysis, 2023

16.11.2.1. By Product

16.11.2.2. By Application

16.11.2.3. By End-User

16.12. Czech Republic

16.12.1. Pricing Analysis

16.12.2. Market Share Analysis, 2023

16.12.2.1. By Product

16.12.2.2. By Application

16.12.2.3. By End-User

16.13. Romania

16.13.1. Pricing Analysis

16.13.2. Market Share Analysis, 2023

16.13.2.1. By Product

16.13.2.2. By Application

16.13.2.3. By End-User

16.14. India

16.14.1. Pricing Analysis

16.14.2. Market Share Analysis, 2023

16.14.2.1. By Product

16.14.2.2. By Application

16.14.2.3. By End-User

16.15. Bangladesh

16.15.1. Pricing Analysis

16.15.2. Market Share Analysis, 2023

16.15.2.1. By Product

16.15.2.2. By Application

16.15.2.3. By End-User

16.16. Australia

16.16.1. Pricing Analysis

16.16.2. Market Share Analysis, 2023

16.16.2.1. By Product

16.16.2.2. By Application

16.16.2.3. By End-User

16.17. New Zealand

16.17.1. Pricing Analysis

16.17.2. Market Share Analysis, 2023

16.17.2.1. By Product

16.17.2.2. By Application

16.17.2.3. By End-User

16.18. China

16.18.1. Pricing Analysis

16.18.2. Market Share Analysis, 2023

16.18.2.1. By Product

16.18.2.2. By Application

16.18.2.3. By End-User

16.19. Japan

16.19.1. Pricing Analysis

16.19.2. Market Share Analysis, 2023

16.19.2.1. By Product

16.19.2.2. By Application

16.19.2.3. By End-User

16.20. South Korea

16.20.1. Pricing Analysis

16.20.2. Market Share Analysis, 2023

16.20.2.1. By Product

16.20.2.2. By Application

16.20.2.3. By End-User

16.21. GCC Countries

16.21.1. Pricing Analysis

16.21.2. Market Share Analysis, 2023

16.21.2.1. By Product

16.21.2.2. By Application

16.21.2.3. By End-User

16.22. South Africa

16.22.1. Pricing Analysis

16.22.2. Market Share Analysis, 2023

16.22.2.1. By Product

16.22.2.2. By Application

16.22.2.3. By End-User

16.23. Israel

16.23.1. Pricing Analysis

16.23.2. Market Share Analysis, 2023

16.23.2.1. By Product

16.23.2.2. By Application

16.23.2.3. By End-User

17. Market Structure Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Market Share Analysis of Top Players

17.3.1. By Regional

17.3.2. By Product

17.3.3. By Application

17.3.4. By End-User

18. Competition Analysis

18.1. Competition Deep Dive

18.1.1. Siemens AG

18.1.1.1. Overview

18.1.1.2. Product Portfolio

18.1.1.3. Profitability by Market Segments

18.1.1.4. Sales Footprint

18.1.1.5. Strategy Overview

18.1.1.5.1. Marketing Strategy

18.1.1.5.2. Product Strategy

18.1.1.5.3. Channel Strategy

18.1.2. GE Healthcare

18.1.2.1. Overview

18.1.2.2. Product Portfolio

18.1.2.3. Profitability by Market Segments

18.1.2.4. Sales Footprint

18.1.2.5. Strategy Overview

18.1.2.5.1. Marketing Strategy

18.1.2.5.2. Product Strategy

18.1.2.5.3. Channel Strategy

18.1.3. Philips Healthcare

18.1.3.1. Overview

18.1.3.2. Product Portfolio

18.1.3.3. Profitability by Market Segments

18.1.3.4. Sales Footprint

18.1.3.5. Strategy Overview

18.1.3.5.1. Marketing Strategy

18.1.3.5.2. Product Strategy

18.1.3.5.3. Channel Strategy

18.1.4. Digirad Corporation

18.1.4.1. Overview

18.1.4.2. Product Portfolio

18.1.4.3. Profitability by Market Segments

18.1.4.4. Sales Footprint

18.1.4.5. Strategy Overview

18.1.4.5.1. Marketing Strategy

18.1.4.5.2. Product Strategy

18.1.4.5.3. Channel Strategy

18.1.5. Surgiceye GmbH.

18.1.5.1. Overview

18.1.5.2. Product Portfolio

18.1.5.3. Profitability by Market Segments

18.1.5.4. Sales Footprint

18.1.5.5. Strategy Overview

18.1.5.5.1. Marketing Strategy

18.1.5.5.2. Product Strategy

18.1.5.5.3. Channel Strategy

18.1.6. Koninklijke Philips N.V.

18.1.6.1. Overview

18.1.6.2. Product Portfolio

18.1.6.3. Profitability by Market Segments

18.1.6.4. Sales Footprint

18.1.6.5. Strategy Overview

18.1.6.5.1. Marketing Strategy

18.1.6.5.2. Product Strategy

18.1.6.5.3. Channel Strategy

18.1.7. Toshiba Medical Systems Corporation

18.1.7.1. Overview

18.1.7.2. Product Portfolio

18.1.7.3. Profitability by Market Segments

18.1.7.4. Sales Footprint

18.1.7.5. Strategy Overview

18.1.7.5.1. Marketing Strategy

18.1.7.5.2. Product Strategy

18.1.7.5.3. Channel Strategy

18.1.8. Neusoft Medical Systems Co., Ltd.

18.1.8.1. Overview

18.1.8.2. Product Portfolio

18.1.8.3. Profitability by Market Segments

18.1.8.4. Sales Footprint

18.1.8.5. Strategy Overview

18.1.8.5.1. Marketing Strategy

18.1.8.5.2. Product Strategy

18.1.8.5.3. Channel Strategy

18.1.9. Mediso Medical Imaging Systems Co., Ltd

18.1.9.1. Overview

18.1.9.2. Product Portfolio

18.1.9.3. Profitability by Market Segments

18.1.9.4. Sales Footprint

18.1.9.5. Strategy Overview

18.1.9.5.1. Marketing Strategy

18.1.9.5.2. Product Strategy

18.1.9.5.3. Channel Strategy

18.1.10. CMR Naviscan Corporation

18.1.10.1. Overview

18.1.10.2. Product Portfolio

18.1.10.3. Profitability by Market Segments

18.1.10.4. Sales Footprint

18.1.10.5. Strategy Overview

18.1.10.5.1. Marketing Strategy

18.1.10.5.2. Product Strategy

18.1.10.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Nuclear Imaging Equipment Market

Nuclear Imaging Equipment Market Forecast by SPECT Systems, Hybrid PET Systems, and Planar Scintigraphy through 2034